Atypical ductal breast hyperplasia
Atypical ductal hyperplasia
Atypia
Atypical glandular cells
Atypical hyperplasia
Atypical lobular hyperplasia
Atypical mole
Atypical squamous cells of undetermined significance
Atypical squamous cells, cannot exclude a high-grade lesion
Atypical teratoid/rhabdoid tumor
Auditory
Auditory brain stem response test
Augmentin
Augmerosen
Auricular
Auricular acupuncture
Aurimmune
Aurora B/C kinase inhibitor GSK1070916A
Aurora kinase inhibitor AT9283
Aurotherapy

Ado-trastuzumab emtansine

Meaning of Ado-trastuzumab emtansine:

A drug used to treat HER2-positive breast cancer. It is used in certain patients who have already been treated with an anticancer drug called trastuzumab and a type of drug called a taxane. It is also being studied in the treatment of other types of cancer. Ado-trastuzumab emtansine contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. Ado-trastuzumab emtansine is a type of antibody-drug conjugate. Also called Kadcyla and T-DM1.

ALSO SEE:  Anti-inflammatory

Leave a Reply

Your email address will not be published. Required fields are marked *